APO CA 0.5 (Cabergoline 0.5 mg)
Pill imprint APO CA 0.5 has been identified as Cabergoline 0.5 mg.
Cabergoline is used in the treatment of hyperprolactinemia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Cabergoline 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about cabergoline
- Other brands: Dostinex
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.